about
Health costs from hospitalization with H1N1 infection during the 2009-2010 influenza pandemic compared with non-H1N1 respiratory infectionsEpidemiological data of multiple sclerosis in the province of Evros, Greece.Fatal Mediterranean spotted fever in Greece.Myocarditis, pancreatitis, polyarthritis, mononeuritis multiplex and vasculitis with symmetrical peripheral gangrene of the lower extremities as a rare presentation of leptospirosis: a case report and review of the literatureSimplified Diagnosis of Cardiovascular Autonomic Neuropathy in Type 2 Diabetes Using Ewing's Battery.Inflammatory markers in middle-aged obese subjects: does obstructive sleep apnea syndrome play a role?Down-regulation of intestinal-type alkaline phosphatase in the tumor vasculature and stroma provides a strong basis for explaining amifostine selectivity.Procalcitonin and procalcitonin kinetics for diagnosis and prognosis of intravascular catheter-related bloodstream infections in selected critically ill patients: a prospective observational study.Accuracy of the Neuropad test for the diagnosis of distal symmetric polyneuropathy in type 2 diabetes.Increased serum levels of uric acid are associated with sudomotor dysfunction in subjects with type 2 diabetes mellitusInterleukin-1 associations in inflammatory bowel disease and the enteropathic seronegative spondylarthritis.Hypoxia inducible factor 1alpha and 2alpha overexpression in inflammatory bowel disease.Clinical differences between influenza A (H1N1) virus and respiratory infection between the two waves in 2009 and 2010Amifostine administration during radiotherapy for cancer patients with genetic, autoimmune, metabolic and other diseases.Human papillomavirus in endometrial adenocarcinomas: infectious agent or a mere "passenger"?Evaluation of sural nerve automated nerve conduction study in the diagnosis of peripheral neuropathy in patients with type 2 diabetes mellitus.The diabetic foot in end stage renal disease.Rickettsia species in human-parasitizing ticks in Greece.Leucocyte esterase reagent strips for the diagnosis of spontaneous bacterial peritonitis: a systematic review.The diabetic hand: a forgotten complication?Oral antidiabetic agents: anti-atherosclerotic properties beyond glucose lowering?Statins in prevention and treatment of severe sepsis and septic shock.Cilostazol in diabetic neuropathy: premature farewell or new beginning?Macrolides: from in vitro anti-inflammatory and immunomodulatory properties to clinical practice in respiratory diseases.Hypovitaminosis D and peripheral arterial disease: emerging link beyond cardiovascular risk factors.APOE gene polymorphisms and diabetic peripheral neuropathy.Endovascular treatment of critical ischemia in the diabetic foot: new thresholds, new anatomies.Mitochondrial triglyceride transfer protein inhibition: new achievements in the treatment of dyslipidemias.Role of endogenous GLP-1 and its agonists in osteopenia and osteoporosis: but we little know until tried.Gevokizumab in type 1 diabetes mellitus: extreme remedies for extreme diseases?Local antibiotic delivery systems in diabetic foot osteomyelitis: time for one step beyond?Umbilical cord serum vascular endothelial growth factor (VEGF) levels in normal pregnancies and in pregnancies complicated by preterm delivery or pre-eclampsia.The potential of SGLT2 inhibitors in phase II clinical development for treating type 2 diabetes.Pharmacokinetic and pharmacodynamic drug evaluation of tofogliflozin for the treatment of type 2 diabetes.Action Plan to combat infections due to carbapenem-resistant, Gram-negative pathogens in acute-care hospitals in Greece.Dapagliflozin for the treatment of type 1 diabetes mellitus.Epidemiology and molecular analysis of intestinal colonization by vancomycin-resistant enterococci in greek hospitals.Point-prevalence survey of healthcare facility-onset healthcare-associated Clostridium difficile infection in Greek hospitals outside the intensive care unit: The C. DEFINE study.Prevalence of drug resistance among HIV-1 treatment-naive patients in Greece during 2003-2015: Transmitted drug resistance is due to onward transmissions.Leptospirosis: a report on a series of five autochthonous cases in a Greek region.
P50
Q30414319-A340E030-A9EC-4EC1-B568-1DD8F952A2B1Q33185343-32E3968F-EA1B-4DF4-983F-F905AF00A661Q33385777-03E94194-BEEE-41ED-B6CD-9586883469C0Q33415655-056E15F8-6D93-4E94-B4F8-6E9CEB99ECA2Q33583044-368A6D06-FD20-46ED-9E13-2E8E56F69603Q33984737-E2CA2B7F-8C37-4CDF-91C2-389295F6B208Q34176271-ACCE9795-C8B6-43A4-9A9C-FA101EBF8DADQ34436184-55B2FA79-F062-46C7-99AC-BFAF966FA034Q35043229-B58CBE2A-AE4B-4EBC-9815-9A7180CC45C7Q35219367-1B96FC81-9679-4937-977B-251F5F04D0AEQ35309145-D67DC870-274E-4033-B64D-0D4BD556AF68Q35586682-D0D2C39D-7F1C-4604-BAB2-A933564FB4F7Q36175398-0E2C3BAA-531F-4BC2-A6D5-775CFD947C70Q36374836-0BC6194C-E260-4942-9806-95DE5F07D3D6Q36444979-6ABD9FEE-B2FA-4EC0-9C61-CB43E6A8D47BQ36845335-935C642E-A109-49A5-B13E-D61C399180FCQ36892436-4C4352E6-A49B-4D4A-BAD0-A2A19890AEDAQ37023844-93016A60-69AB-40F4-94B7-309F5C826A25Q37338874-0EA1F26A-D3BD-4F20-8729-18E1ED291D6BQ37393147-92D6B8A5-85F4-42D2-8590-FB28AE5C64DFQ37597253-C8ECA1B7-2931-4328-AAFE-6EC8B661DE95Q37852855-BCCCB2F7-72CF-472F-8863-E74EF6C721D7Q37867839-F471C059-D6B2-4630-A1A3-CA643DB7496DQ37959271-03FAD932-A2A0-4EC4-A0D4-3AA6CFE14FE1Q38029815-F284CD99-79D3-4DCF-BAAB-FC0C09766277Q38051335-71B9D634-1359-4930-AD56-0A3D1B540428Q38058074-B7C3DE8B-A8A1-48FB-9B4C-77F4E802B495Q38073881-BEDE8CEA-304A-4A56-A971-2A9B3F104296Q38188015-F3078F09-2138-4726-BCD7-B205841A93B0Q38235580-60142654-7E04-413C-908A-4F8FF5F960CEQ38325417-3E626984-8369-4A37-AE79-E864F0512D94Q38343081-3A00FB7C-54DA-4A94-A06E-CCFA5E4224A0Q38908779-7450C63D-CE65-4F03-8281-30B91A81B661Q38936746-C2286EA8-2DD5-4CFC-976D-C53734FA81C1Q39165016-32F0C04E-D3BE-4E5F-87B2-E08C8C721041Q39354776-ACF33AFA-F3EE-4A61-978A-B34669E8804CQ39805026-9452AA1F-6430-42C0-8830-8BEBD5399514Q40091474-6EA59650-F9AD-4D7F-9C20-A9E17813CECEQ40130820-DC20FA91-E522-49EC-B73D-AEAEF320B04CQ40136620-D3CA5026-7D3B-44AD-B283-1279B002EE31
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Efstratios Maltezos
@ast
Efstratios Maltezos
@en
Efstratios Maltezos
@es
Efstratios Maltezos
@nl
Efstratios Maltezos
@sl
type
label
Efstratios Maltezos
@ast
Efstratios Maltezos
@en
Efstratios Maltezos
@es
Efstratios Maltezos
@nl
Efstratios Maltezos
@sl
prefLabel
Efstratios Maltezos
@ast
Efstratios Maltezos
@en
Efstratios Maltezos
@es
Efstratios Maltezos
@nl
Efstratios Maltezos
@sl
P106
P1153
35453512900
P31
P496
0000-0002-5827-2661